World Stroke Organization 
Description: Join us for an engaging and timely webinar exploring the groundbreaking findings of the OCEANIC-STROKE trial and their implications for everyday clinical practice. This expert-led session will provide a comprehensive overview of the landmark study, with a focus on secondary stroke prevention and the emerging role of Factor XI/XIa inhibition. Experts will discuss the main trial results, subgroup analyses, patient populations most likely to benefit, and the future landscape of anticoagulation strategies in stroke prevention.
Moderators: Prof. Octavio Pontes-Neto (Brazil), Prof. Mira Katan (Switzerland)
Speakers and Topics:
- Main Results of OCEANIC-STROKE: A Landmark Trial in Secondary Stroke Prevention – Prof. Mike Sharma (Canada)
- Subgroup Analyses and Clinical Interpretation: Who Benefits Most From Factor XI/XIa Inhibition? – Prof. Valeria Caso (Italy)
- Future Directions of Factor XI/XIa Inhibition in Stroke Prevention – Prof. Mira Katan (Switzerland)
- Interactive Panel Discussion and Q&A
Date & Time: Monday June 15th, 4-5pm (CEST)
This webinar is supported by an unrestricted educational grant by Bayer AG.
Days
Hours
Minutes
Seconds
Webinar Details
Speakers:
- Prof. Valeria Caso, Chief of Neurology-Stroke Unit, Ospedale di Saronno, Italy
- Prof. Mike Sharma, Stroke Neurologist and Associate Professor at the University of Ottawa, Canada
- Prof. Mira Katan, Professor of Neurology at the Faculty of Medicine of the University of Basel, Switzerland
Moderator:
- Prof. Octavio Pontes Neto, Professor of Neurology, University of São Paulo (USP), Ribeirão Preto Medical School, Brazil
- Prof. Mira Katan, Professor of Neurology at the Faculty of Medicine of the University of Basel, Switzerland
